LV232 60mg Clinical Trials

1 actively recruiting trial

Also known as: High-dose group

Pipeline

Phase 2: 1

Top Sponsors

Vigonvita Life Sciences1

Indications

MDD1
Depression1

Other1 trial

Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.